The Engagement Equation: How Site Networks, Sponsors And CROs Can Collaborate To Improve The Patient Experience

Enrollment delays derail up to 80% of clinical trials, costing sponsors millions in daily operational expenses and delayed market access. High dropout rates and steep screen failures further compound these financial losses, driven largely by fragmented execution between sponsors, CROs, and trial sites. When stakeholders operate in silos, patients face confusing expectations and administrative burdens that ultimately lead to high attrition. Addressing these site-level bottlenecks requires unified operational alignment. Centralized contracting and standardized training streamline study startup, while data-driven recruitment and active Principal Investigator involvement help maintain protocol adherence. Deepening community ties and offering tailored patient support further boosts retention while easily fulfilling FDA diversity mandates.

Read the full paper to explore strategies for aligning trial partners, mitigating site burdens, and driving clinical efficiency.